Quent Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$922 Sell
44
-112
-72% -$2.52K ﹤0.01% 1445
2025
Q4
$3.59K Sell
156
-60
-28% -$1.97K ﹤0.01% 1320
2025
Q3
$6.5K Buy
+216
New +$6.48K ﹤0.01% 1098
2025
Q2
Sell
-183
Closed -$6.63K 1018
2025
Q1
$6.63K Sell
183
-14
-7% -$582 ﹤0.01% 969
2024
Q4
$8.29K Sell
197
-29
-13% -$1.44K ﹤0.01% 964
2024
Q3
$12.6K Hold
226
﹤0.01% 974
2024
Q2
$9.29K Buy
226
+14
+7% +$598 ﹤0.01% 1001
2024
Q1
$9.9K Buy
212
+77
+57% +$3.63K ﹤0.01% 1021
2023
Q4
$6.46K Sell
135
-54
-29% -$2.09K ﹤0.01% 1035
2023
Q3
$6.74K Sell
189
-47
-20% -$1.86K ﹤0.01% 1003
2023
Q2
$10.9K Hold
236
﹤0.01% 919
2023
Q1
$9.46K Hold
236
﹤0.01% 930
2022
Q4
$10.9K Buy
+236
New +$9.28K ﹤0.01% 880

Other funds holding RARE